66 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
28 May 24
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
7:17am
SGT-210 under investigation for the treatment of rare hyper-keratinization disorders.
For additional information, please visit our new website
424B3
SLGL
Sol-Gel Technologies Ltd
20 May 24
Prospectus supplement
4:05pm
an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of rare hyper
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
20 May 24
Sol-Gel Reports First Quarter 2024 Financial Results and Provides
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of rare hyper-keratinization disorders.
For additional
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
POS AM
r5os j9lqk1ppp
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.1
yvvuv395b26i6ou5lnq
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
EX-99.1
3jt sspo4
30 Nov 23
Current report (foreign)
7:10am
424B3
30f7kdf lm4yv
9 Nov 23
Prospectus supplement
3:41pm
6-K
EX-99.1
v7la2ay2cp1ck m1w4
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
vc7tw2n
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.1
pg7919n
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
d21je9
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
424B3
qxoj bx4v
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
s03gine
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am